Drs. Cremer, Maza, Alfaro, and Soler, attend “The Affordable Cancer Technologies Conference” at the National Cancer Institute in Washington, D.C., where Dr. Cremer gives a talk on the UH3 regarding a randomized controlled trial comparing cure rates between CryoPen® and thermoablation.
